Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-9,562
Closed -$232K 157
2017
Q3
$232K Buy
+9,562
New +$254K 0.6% 87
2016
Q1
Sell
-10,755
Closed -$61K 209
2015
Q4
$61K Buy
+10,755
New +$60.2K 0.05% 123
2015
Q3
Sell
-13,734
Closed -$52K 242
2015
Q2
$52K Buy
+13,734
New +$44.7K 0.02% 161
2014
Q4
Sell
-13,207
Closed -$20K 259
2014
Q3
$20K Buy
+13,207
New +$42.4K ﹤0.01% 189
2014
Q2
Sell
-11,799
Closed -$42K 271
2014
Q1
$42K Buy
+11,799
New +$80.3K 0.01% 279

Other funds holding EXEL

QCM Cayman's EXEL Position: Q4 2017 in Review

QCM Cayman sold out of Exelixis (EXEL) in Q4 2017, closing a stake of 9,562 shares — an estimated $232K sold.

QCM Cayman first reported a position in EXEL in Q1 2014 and held it in 5 quarters. The position peaked at $232K in Q3 2017. 302 funds tracked by Wall St. Rank hold EXEL as of Q4 2017.

  • QCM Cayman reported no remaining Exelixis position as of Q4 2017 after selling out during the quarter.
  • QCM Cayman sold 9,562 Exelixis shares in Q4 2017, an estimated $232K.
  • QCM Cayman first reported a position in Exelixis in Q1 2014 and held it in 5 quarters.
  • QCM Cayman's Exelixis position peaked at $232K in Q3 2017.
  • 302 funds tracked by Wall St. Rank held Exelixis as of Q4 2017.

Based on QCM Cayman's 13F filing for Q4 2017, filed 14 Feb 2018.